Previous blogs have highlighted concern over “immoral, incoherent and quite possibly illegal" NHS rules denying patients care if they choose to top-up their treatment privately. Now, the health think-tank, the King’s Fund, has said that the NHS should no longer be able to discriminate in such a way.
Currently, patients may lose the right to free NHS care if they pay privately for drugs rejected by the National Institute for Health and Clinical Excellence as not cost-effective. This seems highly inconsistent when people are able to top-up dental and optical treatment, as well as additional non-clinical treatment such as private rooms, but are denied this option when it comes to the prolonging their life.
Niall Dickson, Chief Executive of the King’s Fund, said that: "The current practice on top-ups, which prohibits people from privately purchasing drugs not available on the health service while continuing a course of NHS care, is untenable."
Some of the drugs concerned are not available on the NHS as they are only effective for some patients. The King’s Fund said that if the treatment is effective for the patient, then after a certain time period, particularly if the patient is financially unable to continue using the drug, the NHS should bare the cost.
Up until recently, ministers have said that top-up treatment would cause a two-tier health system, however, after recent high-profile cases of cancer patients being denied life prolonging drugs, they have agreed to reconsider the issue. Professor Sir Mike Richards, cancer expert, is currently preparing a report for ministers reviewing top-up policy that is likely to be ready in the next month.
In a new drive to instil another drop of confidence in his government, Gordon Brown has this week released plans for a £1 billion energy relief programme, but once again he may have missed the spot.
Soft-drink giants Coca-Cola, who recently agreed to pay $2.5 billion for China’s fruit juice company, Huiyuan Juice, must now take the deal to the country’s competition authorities and overcome the regulatory obstructions. This case will draw a great deal of attention as it is potentially the largest foreign acquisition of a Chinese company ever to take place, and the first case to be filed under China’s new anti-trust laws.
This week Google launched their new web browser, Google Chrome. There have been rumours of such a project for some time, though they have only recently come to fruition. The Browser aims to rival Microsoft’s browser Internet Explorer, which currently dominates around 75 percent of the market. Google have already tried to battle with Internet Explorer more indirectly by supporting the open-source browser Mozilla Firefox, however, fears that Microsoft may try to alter their software so that Google products run less efficiently have pushed them to develop their own browser.
In 2007, owners of a house in Bristol, which had acted as a canvas for the infamous graffiti artist Banksy, became frustrated when all potential buyers of their home seemed determined to get rid of the large mural on its side.